As a reputable research service provider, at Protheragen, we specialize in offering extensive services for the development of therapies targeting rare ophthalmic diseases. Our one-stop solutions cater to a range of conditions including congenital eye diseases, hereditary eye diseases, infectious eye diseases, autoimmune eye diseases, and ocular tumor diseases. Our service portfolio encompasses diagnostic development, diverse therapy development, disease model creation, and preclinical research services, all tailored to meet the unique requirements of our clients.
Utilizing next-generation sequencing and bioinformatics, we identify the specific genetic mutations that underlie various congenital eye diseases.
The development of drugs and therapies for hereditary eye diseases involves a multidisciplinary approach, combining genetic research, molecular biology, and preclinical expertise.
Infectious eye diseases are caused by microorganisms such as bacteria, viruses, fungi and parasites. Our company is committed to overcoming the complexities of delivering drugs to the eye.
Our team's deep understanding of the immune system and its role in autoimmune eye diseases allows us to identify and validate targets that are most likely to yield effective therapeutics.
We initiate our drug development process with the identification and validation of molecular targets that are crucial for the growth and survival of ocular tumor cells.
Leveraging extensive expertise, our company crafts bespoke solutions tailored to the specific needs of rare eye disease therapy development.
Karyotype Analysis Service
Biomarker Development Service
Gene Therapy Development
Small Molecule Drug Development
Therapeutic Antibody Development
Disease Model Development
Drug Safety Evaluation
Pharmacokinetics
Protheragen offers a comprehensive portfolio of biospecimens and ocular cell products related to human ophthalmic diseases. With an extensive network of collection sites, we ensure diverse sample acquisition while maintaining strict ethical standards. Additionally, we provide customized solutions to cater to the specific research requirements of our clients.
Protheragen provides high-quality and ethically reviewed aqueous and vitreous humor samples for use in the development of therapeutics for a wide range of ophthalmic diseases.
To meet the different needs of our customers, we provide tear samples from patients with various ophthalmic diseases and healthy donors.
Committed to delivering top-quality and ethically sourced ophthalmic tissue samples from human or animal sources, our focus is on supporting the development of drugs and therapies for ophthalmic diseases.
At Protheragen, we understand the importance of these cells and offer a comprehensive range of eye cell products derived from human or animal sources to support research and therapeutic development.
Copyright © Protheragen. All rights reserved.
